| Peter Light, MD | |
|
2800 10th Ave N, Billings, MT 59101-0703 | |
| (406) 238-2500 | |
| Not Available |
| Full Name | Peter Light |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 34 Years |
| Location | 2800 10th Ave N, Billings, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174676845 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 7617 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Billings Clinic | Billings, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Billings Clinic | 6002993516 | 659 |
News Archive
Arno Therapeutics, Inc. announced today that its Phase II clinical study of AR-67 has met pre-defined interim goals for patients with glioblastoma multiforme (GBM) who were not previously treated with Avastin and will continue toward completion.
Upsher-Smith Laboratories, Inc. announced the launch of Trianex 0.05% (Triamcinolone Acetonide Ointment), a prescription topical corticosteroid offering the feel of a cream with the strength of an ointment.
CombiMatrix Corporation today announced that it received a written notice from The Nasdaq Stock Market (the "Notice") on November 17, 2010 indicating that the Company is not in compliance with the minimum stockholders' equity requirement for continued listing on The Nasdaq Global Market (as set forth in Nasdaq Listing Rule 5450(b)(1)(A)) because the Company's stockholders' equity is below The Nasdaq Global Market minimum stockholders' equity listing requirement of $10,000,000.
For patients with a common kidney disease who have normal kidney function and only minor urinary abnormalities at the time of diagnosis, the long-term prognosis is excellent and no special treatments are needed, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.
› Verified 3 days ago
| Entity Name | Billings Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326104845 PECOS PAC ID: 6002993516 Enrollment ID: O20080430000212 |
News Archive
Arno Therapeutics, Inc. announced today that its Phase II clinical study of AR-67 has met pre-defined interim goals for patients with glioblastoma multiforme (GBM) who were not previously treated with Avastin and will continue toward completion.
Upsher-Smith Laboratories, Inc. announced the launch of Trianex 0.05% (Triamcinolone Acetonide Ointment), a prescription topical corticosteroid offering the feel of a cream with the strength of an ointment.
CombiMatrix Corporation today announced that it received a written notice from The Nasdaq Stock Market (the "Notice") on November 17, 2010 indicating that the Company is not in compliance with the minimum stockholders' equity requirement for continued listing on The Nasdaq Global Market (as set forth in Nasdaq Listing Rule 5450(b)(1)(A)) because the Company's stockholders' equity is below The Nasdaq Global Market minimum stockholders' equity listing requirement of $10,000,000.
For patients with a common kidney disease who have normal kidney function and only minor urinary abnormalities at the time of diagnosis, the long-term prognosis is excellent and no special treatments are needed, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Light, MD Po Box 35100, Billings, MT 59107-5100 Ph: (406) 238-2500 | Peter Light, MD 2800 10th Ave N, Billings, MT 59101-0703 Ph: (406) 238-2500 |
News Archive
Arno Therapeutics, Inc. announced today that its Phase II clinical study of AR-67 has met pre-defined interim goals for patients with glioblastoma multiforme (GBM) who were not previously treated with Avastin and will continue toward completion.
Upsher-Smith Laboratories, Inc. announced the launch of Trianex 0.05% (Triamcinolone Acetonide Ointment), a prescription topical corticosteroid offering the feel of a cream with the strength of an ointment.
CombiMatrix Corporation today announced that it received a written notice from The Nasdaq Stock Market (the "Notice") on November 17, 2010 indicating that the Company is not in compliance with the minimum stockholders' equity requirement for continued listing on The Nasdaq Global Market (as set forth in Nasdaq Listing Rule 5450(b)(1)(A)) because the Company's stockholders' equity is below The Nasdaq Global Market minimum stockholders' equity listing requirement of $10,000,000.
For patients with a common kidney disease who have normal kidney function and only minor urinary abnormalities at the time of diagnosis, the long-term prognosis is excellent and no special treatments are needed, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.
› Verified 3 days ago
Dr. Mark David Schaefer, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-4116 | |
Richard Lammers, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-4116 Fax: 406-237-4125 | |
Deniz Tek, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-4116 Fax: 406-237-4125 | |
Jedediah Owen Walker, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
James Evan Buchan, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-4116 Fax: 406-237-4125 | |
Samuel Leon Paczkowski, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-4116 Fax: 406-237-4125 | |
Douglas Parker, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-4116 Fax: 406-237-4125 |